On January 16, 2026, the U.S. Food and Drug Administration (FDA) released a statement saying they had granted full approval ...

The FDA has granted full approval to verdinexor tablets (Laverdia; Anivive Lifesciences) for the treatment of dogs with lymphoma. The approval gives veterinarians a promising new oral avenue for ...

"My 12-year-old dog Oliver has been diagnosed with lymphoma. Naturally, the vet has referred me to an oncology vet. I do not want to put the dog through chemo, and I asked the vet if he would treat ...

Panel expansion planned over the next three years to cover the majority of canine cancer cases, transforming cancer detection and supporting earlier intervention "Building on over 40 years of IDEXX's ...

The U.S. Food and Drug Administration (FDA) has granted full approval of Laverdia, a drug to treat dogs with lymphoma, a type of cancer of the lymph nodes and lymphatic system.

Clinical trial sites across nine states have closed for one of the largest canine lymphoma studies Effectiveness data will soon be finalized for statistical review and FDA submission LONG BEACH, Calif ...

Christina Pacholec is a Ph.D. student conducting research on using AI to diagnose cancer in dogs. Photo by Andrew Mann for Virginia Tech. A pioneering research project led by Ph.D. student Christina ...

Innovative research for a dog cancer treatment from the University of Missouri College of Veterinary Medicine has shown early ...

Canine lymphoma represents one of the most common haematological malignancies in dogs and is increasingly recognised as a robust comparative model for human non‐Hodgkin lymphoma. Recent efforts have ...